{"heading":"HB03252","0":"AN ACT ESTABLISHING THE DRUG PRICE REGULATORY BOARD TO REGULATE THE PRICES OF DRUGS AND MEDICINES IN THE PHILIPPINES AMENDING FOR THE PURPOSE REPUBLIC ACT NO. 9502, OTHERWISE KNOWN AS THE 'UNIVERSALLY ACCESSIBLE CHEAPER AND QUALITY MEDICINES ACT OF 2008' AND FOR OTHER PURPOSES","principal-authors":" BIRON, FERJENEL G. M.D.","primary-referral":" TRADE AND INDUSTRY","status":" Deliberated upon by the Mother Committee on 2018-02-05","historyid":"#HB03252-17","docs":[{"doclabel":"[Text As Filed]","docurl":"congress.gov.ph\/legisdocs\/basic_17\/HB03252.pdf"}],"history":"\u003Ctable width=\"auto\"  border=\"0\" cellspacing=\"0\" cellpadding=\"0\"\u003E\u003Ctr\u003E\u003Ctd colspan=3\u003EHouse Bill\/Resolution NO. \u003Cb\u003EHB03252\u003C\/b\u003E\u003C\/td\u003E\u003C\/tr\u003E\u003Ctr\u003E\u003Ctd colspan=3\u003EFULL TITLE : AN ACT ESTABLISHING THE DRUG PRICE REGULATORY BOARD TO REGULATE THE PRICES OF DRUGS AND MEDICINES IN THE PHILIPPINES AMENDING FOR THE PURPOSE REPUBLIC ACT NO. 9502, OTHERWISE KNOWN AS THE 'UNIVERSALLY ACCESSIBLE CHEAPER AND QUALITY MEDICINES ACT OF 2008' AND FOR OTHER PURPOSES\u003C\/td\u003E\u003C\/tr\u003E\u003Ctr\u003E\u003Ctd colspan=3\u003EPRINCIPAL AUTHOR\/S : \u003Cb\u003EBIRON, FERJENEL G. M.D.\u003C\/b\u003E\u003C\/td\u003E\u003C\/tr\u003E\u003Ctr\u003E\u003Ctd colspan=3\u003EDATE FILED : 2016-08-24\u003C\/td\u003E\u003C\/tr\u003E\u003Ctr\u003E\u003Ctd colspan=3\u003ESIGNIFICANCE: NATIONAL\u003C\/td\u003E\u003C\/tr\u003E\u003Ctr\u003E\u003Ctd colspan=3\u003ENATURE : Reform\u003C\/td\u003E\u003C\/tr\u003E\u003Ctr\u003E\u003Ctd colspan=3\u003ECO-AUTHORS (Journal Entries) :\u003C\/td\u003E\u003C\/tr\u003E\u003Ctr\u003E\u003Ctd\u003E1. Dalipe (000 2017-10-09)\u003C\/td\u003E\u003Ctd\u003E2. Castelo (000 2017-10-10)\u003C\/td\u003E\u003Ctr\u003E\u003Ctd\u003E3. Belmonte (R.) (000 2018-02-14)\u003C\/td\u003E\u003Ctr\u003E\u003Ctd colspan=3\u003E\u003Cb\u003EACTIONS TAKEN BY THE COMMITTEE\u003C\/b\u003E\u003C\/td\u003E\u003C\/tr\u003E\u003Ctr\u003E\u003Ctd colspan=3\u003ECOMMITEE HEARINGS\/ACTIONS:\u003C\/td\u003E\u003C\/tr\u003E\u003Ctr\u003E\u003Ctd colspan=3\u003E\u003Cb\u003E&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp1. Referred to Stakeholders on 2017-08-01\u003C\/b\u003E\u003Ctr\u003E\u003Ctd colspan=3\u003E\u003Cb\u003E&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp2. Deliberated upon by the Mother Committee on 2017-08-14\u003C\/b\u003E\u003Ctr\u003E\u003Ctd colspan=3\u003E\u003Cb\u003E&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp3. Deliberated by the TWG on 2017-12-11\u003C\/b\u003E\u003Ctr\u003E\u003Ctd colspan=3\u003E\u003Cb\u003E&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp4. Deliberated upon by the Mother Committee on 2018-02-05\u003C\/b\u003E\u003Ctr\u003E\u003Ctd colspan=3\u003E&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp-Deliberation and approval of Draft Bill prepared by the TWG in substitution of HBs 3252 and 6332 re: Amending Certain Provisions of RA 9502, \"Universally Accessible Cheaper Quality Medicines Act of 2008\".\u003C\/td\u003E\u003C\/tr\u003E\u003Ctr\u003E\u003Ctd colspan=3\u003E\u003Cb\u003EACTIONS TAKEN BY THE COMMITTEE ON RULES\u003C\/b\u003E\u003C\/td\u003E\u003C\/tr\u003E\u003Ctr\u003E\u003Ctd colspan=3\u003EREFERRAL TO THE COMMITTEE ON TRADE AND INDUSTRY ON 2016-08-31\u003C\/td\u003E\u003C\/tr\u003E\u003C\/table\u003E"}